Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03420833 · ClinicalTrials.gov registry record · NA
Metabolic Mapping and Cardiac Resynchronization
A NA study, sponsored by Yong-Mei Cha.
- Completed
- Registry status
- NA
- Development phase
- 82
- Enrollment target
NCT03420833 is a NA study that has completed, run by Yong-Mei Cha. The registered enrollment target is 82 participants.
The verdict
NCT03420833, a NA study, has completed, sponsored by Yong-Mei Cha.
- COMPLETED
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
Study Summary
The purpose of this study is to gather information on the safety and effectiveness of cardiac resynchronization therapy (CRT) in patients who have mild heart failure (HF) and left bundle branch block (LBBB).
Interventions
- DEVICE Cardiac resynchronization therapy pacemaker (CRT-P)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2018-08-20 |
| Est. Completion | 2023-12-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03420833
The ClinicalTrials.gov registry entry for NCT03420833 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yong-Mei Cha, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac resynchronization therapy pacemaker (CRT-P) is the first listed.
NCT03420833 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03420833 about?
NCT03420833 is a clinical study titled "Metabolic Mapping and Cardiac Resynchronization". The purpose of this study is to gather information on the safety and effectiveness of cardiac resynchronization therapy (CRT) in patients who have mild heart failure (HF) and left bundle branch block (LBBB).
What is the current status of trial NCT03420833?
This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2018-08-20. Estimated completion is 2023-12-19.
What interventions are being tested in trial NCT03420833?
The interventions under investigation include: Cardiac resynchronization therapy pacemaker (CRT-P) (DEVICE).
Who is sponsoring clinical trial NCT03420833?
This trial is sponsored by Yong-Mei Cha, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.